| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 03/27/2001 | US6207457 Targeted nucleotide sequence delivery and integration system |
| 03/27/2001 | US6207456 Nucleic acid delivery vehicle |
| 03/27/2001 | US6207453 A replication-defective adeno-associated virus vector containing exogenous dna bound to a dna which codes for a rep protein; gene therapy |
| 03/27/2001 | US6207451 Includes substrate, separate anchors joined to substrate, and myogenic precursor cells; anchors allow cells to attach to form three dimensional construct; drug screening; toxicity testing; gene therapy; screening of congenital disorders |
| 03/27/2001 | US6207450 Nucleic acid of defined nucleotide sequence which encodes fkhl7 protein; drug screening; primers; probes; gene therapy; antibodies; recombinant production |
| 03/27/2001 | US6207426 Preparing preferentially propagating microorganism plasmid; obtain plasmid, insert preferential nucleotide sequences, evaluate propagation in cells |
| 03/27/2001 | US6207418 Production of a multimeric protein by cell fusion method |
| 03/27/2001 | US6207417 DNA encoding stem cell factor |
| 03/27/2001 | US6207415 Preparing polypeptides in poultry embryonic tissues; propagating poultry tissues until tissue begins senescence, concentrating tissues, isolate non-senescent cells and propagate, recover polypeptides from tissues |
| 03/27/2001 | US6207413 Nucleotide sequence coding binding protein; for the diagnosis and treatment of endocrine defects |
| 03/27/2001 | US6207401 Diagnosis and treatment of AUR-1 and/or AUR-2 related disorders |
| 03/27/2001 | US6207383 Adjusted nucleotide sequences associated with genetic disorder; for the diagnosis, treatment and prevention of arrhythmia |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | US6207371 Classification of genetically engineered eucaryotic aggregations |
| 03/27/2001 | US6207169 Compounds and methods for the diagnosis and treatment of Ehrlichia infection |
| 03/27/2001 | US6207161 Genetic engineering |
| 03/27/2001 | US6207156 Specific antibodies and antibody fragments |
| 03/27/2001 | US6207153 Antigen binding polypeptide |
| 03/27/2001 | US6207152 Anticancer agent |
| 03/27/2001 | US6207147 Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 03/27/2001 | US6207146 Gene expression in mammalian cells |
| 03/27/2001 | US6206931 Purified, biocompatible, collagen-based matrix structure from submucosa tissue source with an endotoxin level of 12 or less units per gram |
| 03/27/2001 | US6206914 Implantable system with drug-eluting cells for on-demand local drug delivery |
| 03/27/2001 | CA2076540C Recombinant antibodies specific for tnf-.alpha. |
| 03/27/2001 | CA2065860C Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 03/27/2001 | CA2034054C Cryopreservation process for direct transfer of embryos |
| 03/27/2001 | CA1341208C Proteins with factor viii activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them |
| 03/23/2001 | WO2001019976A2 Plant regulatory sequences for control of gene expression |
| 03/23/2001 | CA2388370A1 Plant regulatory sequences for control of gene expression |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020031A2 Polymorphisms in a klotho gene |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001020015A1 Reverse transfection method |
| 03/22/2001 | WO2001020013A2 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | WO2001020012A2 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
| 03/22/2001 | WO2001020011A1 Dna construct and its use |
| 03/22/2001 | WO2001020009A1 Plants having altered amino acid contents and method for the production thereof |
| 03/22/2001 | WO2001020004A2 Protein phosphatase and kinase proteins |
| 03/22/2001 | WO2001020003A2 Variants of the gamma chain of ampk, dna sequences encoding the same, and uses thereof |
| 03/22/2001 | WO2001020002A1 Thermostable luciferases from photuris pennsylvanica and pyrophorus plagiophthalamus and methods of production |
| 03/22/2001 | WO2001019992A2 FACTOR IX/FACTOR IXa ANTIBODIES AND ANTIBODY DERIVATIV ES |
| 03/22/2001 | WO2001019985A1 Novel receptors and genes encoding the same |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019977A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation and methods for enhancing embryonic development by genetic alteration of donor cells or by tissue culture conditions |
| 03/22/2001 | WO2001019975A2 Plants having reduced activity in two or more starch-modifying enzymes |
| 03/22/2001 | WO2001019974A2 Recombinant microorganisms |
| 03/22/2001 | WO2001019973A2 Nicotinic acetylcholine receptor: alpha10 subunit |
| 03/22/2001 | WO2001019968A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 03/22/2001 | WO2001019967A1 Human inflammatory breast carcinoma xenograft capable of lymphovascular invasion and methods for its use |
| 03/22/2001 | WO2001019966A2 Isolation of muscle-derived stem cells and uses therefor |
| 03/22/2001 | WO2001019965A1 Methods and compositions for preserving chondrocytes and uses |
| 03/22/2001 | WO2001019964A1 Chondrocyte compositions, preparation and use thereof |
| 03/22/2001 | WO2001019963A2 System and method for microwave cell lysing of small samples |
| 03/22/2001 | WO2001019962A2 Method of preserving tissue viability during mechanical separation process |
| 03/22/2001 | WO2001019961A2 Method for cultivating living cells, especially mature fat cells, which are prepared from tissue and float in liquids |
| 03/22/2001 | WO2001019956A2 A method for isolation of prostatic epithelial cells from semen |
| 03/22/2001 | WO2001019955A2 Lysosomal targeting pathway enzymes |
| 03/22/2001 | WO2001019871A2 Delivery system for antidandruff agent |
| 03/22/2001 | WO2001019870A2 Secreted soluble alpha2delta-2, alpha2delta-3, alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | WO2001019866A1 Dipeptidyl peptidases |
| 03/22/2001 | WO2001019861A2 Apo-2 receptor antibodies |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019855A2 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | WO2001019851A2 Opaminergic neuronal survival-promoting factors and uses thereof |
| 03/22/2001 | WO2001019842A1 Subunit optimized fusion proteins |
| 03/22/2001 | WO2001019800A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 03/22/2001 | WO2001019410A2 Human flash and uses thereof |
| 03/22/2001 | WO2001019379A2 Methods for treating muscular dystrophy with bone marrow cells |
| 03/22/2001 | WO2001019182A1 Nuclear transfer with selected donor cells |
| 03/22/2001 | WO2001009332A3 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 03/22/2001 | WO2001007636A3 Maize dna ligase ii orthologue and uses thereof |
| 03/22/2001 | WO2001006843A3 Promotion of proliferation of adult corneal endothelial cells |
| 03/22/2001 | WO2001000811A3 17867, a novel human aminopeptidase |
| 03/22/2001 | WO2000073323A3 Adam polynucleotides and polypeptides |
| 03/22/2001 | WO2000071693A3 Method for selecting improved vectors |
| 03/22/2001 | WO2000066623A3 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
| 03/22/2001 | WO2000065038A3 Methods, compositions, and cells for encapsidating recombinant vectors in aav particles |
| 03/22/2001 | WO2000060066A8 Protein-protein from s. cerevisiae and methods of using same |
| 03/22/2001 | WO2000059943A3 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE |
| 03/22/2001 | WO2000058453A3 Plants transformed with thioredoxin |
| 03/22/2001 | WO2000056861A8 Methods of microencapsulating pancreatic islet cells |
| 03/22/2001 | WO2000056808A3 Surface and its manufacture and uses |
| 03/22/2001 | WO2000055318A3 Abc1 polypeptide and methods and reagents for modulating cholesterol levels |
| 03/22/2001 | WO2000052142A3 Culture medium comprising meiosis activating sterols (mas) and method for in vitro fertilisation |
| 03/22/2001 | WO2000044882A8 Methods and compositions for the differentiation of human preadipocytes into adipocytes |
| 03/22/2001 | WO2000024249A3 Compositions comprising plant cell growth regulating compounds and methods of use thereof |
| 03/22/2001 | WO2000020591A9 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 03/22/2001 | WO2000018421A9 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 03/22/2001 | WO1999061605A3 System for reproducing and modulating stability and turnover of rna molecules |
| 03/22/2001 | WO1999058678A9 Antibodies to dendritic cells and human dendritic cell populations and uses thereof |
| 03/22/2001 | CA2388364A1 Plants having reduced activity in two or more starch-modifying enzymes |
| 03/22/2001 | CA2386559A1 Isolation of muscle-derived stem cells and uses therefor |
| 03/22/2001 | CA2386530A1 Viral replicons and viruses dependent on inducing agents |
| 03/22/2001 | CA2385308A1 Secreted soluble alpha2delta-2, alpha2delta-3, or alpha2delta-4 calcium channel subunit polypeptides and screening assays using same |
| 03/22/2001 | CA2384990A1 System and method for microwave cell lysing of small samples |
| 03/22/2001 | CA2384916A1 Plants having altered amino acid contents and method for the production thereof |
| 03/22/2001 | CA2384860A1 Recombinant eggs and gene cloning and expression vectors based on avian adenoviruses |
| 03/22/2001 | CA2384768A1 Methods and compositions for preserving chondrocytes and uses |